Thermo Fisher Reports Q1 2026 Earnings with Revenue Growth and Margin Decline
Thermo Fisher (TMO) reported Q1 2026 earnings with revenue of $11.01 billion, up 6% year-over-year, driven by organic growth, acquisitions, and favorable foreign exchange. Adjusted operating income rose 6% to $2.4 billion, but adjusted operating margin declined slightly to 21.8% due to tariffs and foreign exchange impacts. The company also announced the closure of the Clario acquisition, contributing to revenue and EPS.
Tickers: $TMO
Topics: acquisition buybacks earnings EPS operating income revenue